Monday, 06 July 2020

Cipla supports Siliguri in the fight against COVID-19

14 May 2020 | News

Extends support to marginalized families through ActionAid India

Source: Shutterstock

Source: Shutterstock

Cipla has announced a number of initiatives that it has undertaken to tackle the COVID-19 pandemic in Siliguri. The Company recently launched an INR 25 crore ‘Caring for Life’ COVID-19 dedicated Fund to further several immediate and long-term relief efforts that the country needs to combat the crisis.

Through its wide-ranging relief measures pan India, the Company is focusing on initiatives that have the maximum impact and reach. In Siliguri, its efforts are primarily targeted at the safety and wellbeing of its employees as well as the lesser-privileged members of the community who have low access to basic necessities.

Through a specially constituted central COVID-19 taskforce, Cipla Siliguri has designed an effective mechanism comprising various aspects to safeguard its employees. The Company is undertaking frequent sanitisation of the facility premises, employee transport vehicles and Goods carriers. All employees are provided with sanitizers, masks, hand gloves and safety goggles to ensure personal protection.

The Company is ensuring business continuity so that manufacturing and distribution of essential medicines can continue for patients in these difficult times. Cipla has also launched a toll-free helpline to assist its patients in procuring essential medication across therapies from pharmacies and health-care institutions.

In furtherance of its responsibility to the community, the Company has collaborated with ActionAid India to ensure the wellbeing of 100 families in need, who reside in the vicinity of the Cipla depot. As part of this, a total of 108 ration kits have been distributed. In addition, the Company has been supporting long distance truckers engaged in the transportation of goods to and fro for Cipla with ration kit

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account